Holen Sie sich die Stockscreener-App
19.19
1.16%
0.22
Handel nachbörslich:
19.00
-0.19
-0.99%
Schlusskurs vom Vortag:
$18.97
Offen:
$18.96
24-Stunden-Volumen:
694.04K
Relative Volume:
0.46
Marktkapitalisierung:
$950.15M
Einnahmen:
$239.44M
Nettoeinkommen (Verlust:
$-80.45M
KGV:
-11.77
EPS:
-1.6303
Netto-Cashflow:
$-40.05M
1W Leistung:
+3.28%
1M Leistung:
-4.67%
6M Leistung:
-28.26%
1J Leistung:
+9.91%
1-Tages-Spanne:
$18.66
$19.34
1-Wochen-Bereich:
$16.83
$19.34
52-Wochen-Spanne:
$14.69
$30.81
Staar Surgical Co Stock (STAA) Company Profile
Firmenname
Staar Surgical Co
Sektor
Telefon
(626) 303-7902
Adresse
1911 WALKER AVE, MONROVIA, CA
Compare STAA vs ISRG, BDX, ALC, MDLN, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
STAA
Staar Surgical Co
|
19.19 | 939.26M | 239.44M | -80.45M | -40.05M | -1.6303 |
ISRG
Intuitive Surgical Inc
|
469.98 | 167.61B | 10.06B | 2.88B | 2.49B | 7.876 |
BDX
Becton Dickinson Co
|
158.27 | 44.35B | 21.92B | 1.76B | 2.63B | 6.1223 |
ALC
Alcon Inc
|
75.26 | 36.19B | 10.40B | 980.00M | 1.61B | 1.9749 |
MDLN
Medline Inc
|
42.67 | 34.11B | 28.43B | 1.16B | 1.26B | 1.4457 |
RMD
Resmed Inc
|
226.31 | 33.24B | 5.40B | 1.49B | 1.78B | 10.12 |
Staar Surgical Co Stock (STAA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-03 | Eingeleitet | Wedbush | Neutral |
| 2026-01-16 | Fortgesetzt | Morgan Stanley | Underweight |
| 2025-04-21 | Eingeleitet | Wells Fargo | Equal Weight |
| 2025-02-12 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-02-12 | Herabstufung | Jefferies | Buy → Hold |
| 2025-02-12 | Herabstufung | Mizuho | Outperform → Neutral |
| 2025-02-12 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2024-07-15 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2024-06-11 | Hochstufung | BTIG Research | Neutral → Buy |
| 2024-03-11 | Hochstufung | Stifel | Hold → Buy |
| 2023-12-05 | Herabstufung | Needham | Buy → Hold |
| 2023-12-04 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2023-09-15 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2023-08-03 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2023-06-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-04-17 | Eingeleitet | Piper Sandler | Neutral |
| 2023-02-06 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-12-28 | Bestätigt | BTIG Research | Buy |
| 2022-12-08 | Eingeleitet | Stifel | Hold |
| 2022-11-07 | Hochstufung | Sidoti | Neutral → Buy |
| 2022-10-14 | Fortgesetzt | Stephens | Overweight |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2022-04-08 | Eingeleitet | Needham | Buy |
| 2022-03-28 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2022-03-18 | Hochstufung | BTIG Research | Neutral → Buy |
| 2021-07-09 | Eingeleitet | Oppenheimer | Perform |
| 2021-01-19 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2020-10-26 | Herabstufung | Sidoti | Buy → Neutral |
| 2020-08-31 | Hochstufung | Sidoti | Neutral → Buy |
| 2020-08-06 | Bestätigt | The Benchmark Company | Buy |
| 2020-07-06 | Herabstufung | Sidoti | Buy → Neutral |
| 2020-06-24 | Herabstufung | BTIG Research | Buy → Neutral |
| 2020-06-15 | Eingeleitet | Jefferies | Buy |
| 2019-12-04 | Eingeleitet | BTIG Research | Buy |
| 2018-09-24 | Bestätigt | The Benchmark Company | Buy |
| 2018-08-06 | Fortgesetzt | The Benchmark Company | Buy |
| 2017-11-20 | Bestätigt | The Benchmark Company | Buy |
| 2017-08-14 | Bestätigt | The Benchmark Company | Buy |
| 2017-03-03 | Bestätigt | The Benchmark Company | Buy |
| 2016-05-18 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2013-09-10 | Fortgesetzt | The Benchmark Company | Buy |
| 2013-02-28 | Bestätigt | The Benchmark Company | Buy |
| 2012-11-01 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2012-03-02 | Eingeleitet | Northland Securities | Outperform |
| 2011-10-25 | Bestätigt | The Benchmark Company | Buy |
| 2010-10-12 | Eingeleitet | Morgan Joseph | Buy |
| 2010-05-11 | Eingeleitet | Benchmark | Buy |
Alle ansehen
Staar Surgical Co Aktie (STAA) Neueste Nachrichten
STAAR Surgical: Despite Promises Of Improvement, Investors Should Stay Cautious (STAA) - Seeking Alpha
STAAR Surgical Co stock faces acquisition scrutiny as Alcon deal advances amid analyst caution - AD HOC NEWS
Midday Stock Roundup: Mobix Lab Shares Fall 15% - Orange County Business Journal
STAA gains FDA nod to expand EVO ICL age indication to 60 years - MSN
STAAR Surgical (NASDAQ:STAA) Trading 4.5% HigherWhat's Next? - MarketBeat
STAAR Surgical Company $STAA Stake Boosted by Yunqi Capital Ltd - MarketBeat
LENSAR Stock Plunges—Alcon Scraps Merger After Prolonged Regulatory Review - Benzinga
STAAR Surgical (STAA) awards 39,809 RSUs to Interim Co-CEO Andrews - Stock Titan
[Form 4] STAAR SURGICAL CO Insider Trading Activity - Stock Titan
The Chart That Says You're Right on STAAR Surgical - AOL.com
STAAR Surgical (NASDAQ:STAA) Director Acquires $5,425,707.84 in Stock - MarketBeat
STAAR Surgical (NASDAQ:STAA) Director Broadwood Partners, L.P. Purchases 316,017 Shares - MarketBeat
Broadwood boosts STAAR Surgical (STAA) stake with 670K-share open-market buys - Stock Titan
Refractive Vision Correction Market is expected to hit US$ 8.53 - openPR.com
Director at STAAR Surgical (STAA) receives 7,524 long-dated options - Stock Titan
STAAR Surgical (STAA) awards director 7,524 stock options vesting in 2026 - Stock Titan
Director at STAAR Surgical (STAA) receives grant of 7,524 stock options - Stock Titan
Canaccord reiterates Hold on STAAR Surgical stock, $22 target - Investing.com Nigeria
STAAR Surgical Company (NASDAQ:STAA) Q4 2025 earnings call transcript - MSN
Stifel cuts Staar Surgical stock price target on weak Q4 results - Investing.com Nigeria
Staar Surgical taps Amico Group as Middle East distributor - Arab News PK
STAAR Surgical Co. Experiences Revision in Stock Evaluation Amid Market Challenges - Markets Mojo
STAAR Surgical Co. Experiences Evaluation Revision Amidst Fluctuating Market Conditions - Markets Mojo
GABELLI & Co INVESTMENT ADVISERS INC. Makes New $4.81 Million Investment in STAAR Surgical Company $STAA - MarketBeat
STAAR Surgical net loss hits USD 18.3M in Q4 2025 - Medical Buyer
STAA: Wells Fargo Lowers Price Target by 47.97% on Staar Surgica - GuruFocus
Wells Fargo & Company Cuts STAAR Surgical (NASDAQ:STAA) Price Target to $16.00 - MarketBeat
STAAR Surgical Company (NASDAQ:STAA) Q4 2025 Earnings Call Transcript - Insider Monkey
STAAR Surgical (STAA) Posts US$80.4 Million Annual Loss Testing Turnaround Narratives - simplywall.st
STAAR Surgical Releases Q4 and Full Year 2025 Financial Results - VisionMonday.com
Canaccord reiterates Hold on STAAR Surgical stock, $22 target By Investing.com - Investing.com Canada
Needham maintains Hold on STAAR Surgical stock after Q4 miss - Investing.com Nigeria
Staar Surgical Posts Q4 Loss After Rejecting Alcon Deal - Medical Device and Diagnostic industry
STAAR Surgical Q4 2025 Earnings Report: Revenue Growth & Analyst OutlookNews and StatisticsIndexBox - IndexBox - Market Intelligence Platform
STAAR Surgical (NASDAQ:STAA) Shares Gap Down Following Weak Earnings - MarketBeat
Staar Surgical Q4 2025 Earnings: Revenue and Earnings Miss EstimatesNews and StatisticsIndexBox - IndexBox - Market Intelligence Platform
STAA Analyst Rating Update: Stifel Lowers Price Target | STAA St - GuruFocus
Stifel Nicolaus Issues Pessimistic Forecast for STAAR Surgical (NASDAQ:STAA) Stock Price - MarketBeat
A Glimpse Into The Expert Outlook On Staar Surgical Through 7 Analysts - Benzinga
STAAR Surgical Company Q4 2025 Earnings Call Summary - Yahoo Finance
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
STAAR Surgical earnings missed by $0.52, revenue topped estimates - Investing.com South Africa
STAAR Surgical (NASDAQ:STAA) Misses Q4 CY2025 Sales Expectations, Stock Drops 11.2% - The Globe and Mail
Staar Surgical Co (STAA) Q4 2025 Earnings Call Highlights: Stron - GuruFocus
STAAR Surgical Q4 2025 Earnings Call Transcript - MarketBeat
STAAR Surgical Q4 Earnings Call Highlights - MarketBeat
Earnings call transcript: STAAR Surgical Q4 2025 misses EPS forecast, stock dips - Investing.com Nigeria
Staar Surgical co-CEOs address shareholders, poor Q4 earnings - MassDevice
STAAR Surgical names interim co-CEOs, targets 2026 growth - Investing.com Australia
STAA Reports Lower Q4 Revenue Amidst Inventory Adjustments and M - GuruFocus
STAAR Surgical stock plunges 12% on unexpected Q4 loss By Investing.com - Investing.com Canada
Finanzdaten der Staar Surgical Co-Aktie (STAA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.95%
0.04%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):